Annual EPS
-$0.12
+$0.03+20.00%
31 December 2023
Summary:
Lineage Cell Therapeutics annual earnings per share is currently -$0.12, with the most recent change of +$0.03 (+20.00%) on 31 December 2023. During the last 3 years, it has risen by +$0.02 (+14.29%). LCTX annual EPS is now -135.29% below its all-time high of $0.34, reached on 31 December 2016.LCTX EPS Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Quarterly EPS
-$0.02
+$0.01+33.33%
30 September 2024
Summary:
Lineage Cell Therapeutics quarterly earnings per share is currently -$0.02, with the most recent change of +$0.01 (+33.33%) on 30 September 2024. Over the past year, it has increased by +$0.02 (+50.00%). LCTX quarterly EPS is now -103.77% below its all-time high of $0.53, reached on 30 September 2018.LCTX Quarterly EPS Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
TTM EPS
-$0.11
+$0.02+15.38%
30 September 2024
Summary:
Lineage Cell Therapeutics TTM earnings per share is currently -$0.11, with the most recent change of +$0.02 (+15.38%) on 30 September 2024. Over the past year, it has increased by +$0.02 (+15.38%). LCTX TTM EPS is now -111.34% below its all-time high of $0.97, reached on 31 March 2017.LCTX TTM EPS Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
LCTX EPS Performance
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1 y1 year | +20.0% | +50.0% | +15.4% |
| 3 y3 years | +14.3% | +60.0% | -37.5% |
| 5 y5 years | +66.7% | +81.8% | +69.4% |
LCTX EPS High & Low
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
|---|---|---|---|---|---|---|---|
| 3 y | 3 years | at high | +53.9% | at high | +88.2% | -37.5% | +63.3% |
| 5 y | 5 years | -50.0% | +66.7% | -300.0% | +88.2% | -175.0% | +72.5% |
| alltime | all time | -135.3% | +85.2% | -103.8% | +96.9% | -111.3% | +90.3% |
Lineage Cell Therapeutics EPS History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Sept 2024 | - | -$0.02(-33.3%) | -$0.11(-15.4%) |
| June 2024 | - | -$0.03(-25.0%) | -$0.13(0.0%) |
| Mar 2024 | - | -$0.04(+100.0%) | -$0.13(+8.3%) |
| Dec 2023 | -$0.12(-20.0%) | -$0.02(-50.0%) | -$0.12(-7.7%) |
| Sept 2023 | - | -$0.04(+33.3%) | -$0.13(0.0%) |
| June 2023 | - | -$0.03(0.0%) | -$0.13(-7.1%) |
| Mar 2023 | - | -$0.03(0.0%) | -$0.14(-6.7%) |
| Dec 2022 | -$0.15(-42.3%) | -$0.03(-25.0%) | -$0.15(-48.3%) |
| Sept 2022 | - | -$0.04(0.0%) | -$0.29(-3.3%) |
| June 2022 | - | -$0.04(0.0%) | -$0.30(+3.4%) |
| Mar 2022 | - | -$0.04(-76.5%) | -$0.29(+11.5%) |
| Dec 2021 | -$0.26(+85.7%) | -$0.17(+240.0%) | -$0.26(+225.0%) |
| Sept 2021 | - | -$0.05(+66.7%) | -$0.08(0.0%) |
| June 2021 | - | -$0.03(+200.0%) | -$0.08(-11.1%) |
| Mar 2021 | - | -$0.01(-200.0%) | -$0.09(-35.7%) |
| Dec 2020 | -$0.14(+75.0%) | $0.01(-120.0%) | -$0.14(-22.2%) |
| Sept 2020 | - | -$0.05(+25.0%) | -$0.18(-25.0%) |
| June 2020 | - | -$0.04(-33.3%) | -$0.24(-40.0%) |
| Mar 2020 | - | -$0.06(+100.0%) | -$0.40(+900.0%) |
| Dec 2019 | -$0.08(-77.8%) | -$0.03(-72.7%) | -$0.04(-88.9%) |
| Sept 2019 | - | -$0.11(-45.0%) | -$0.36(-228.6%) |
| June 2019 | - | -$0.20(-166.7%) | $0.28(-37.8%) |
| Mar 2019 | - | $0.30(-185.7%) | $0.45(-228.6%) |
| Dec 2018 | -$0.36(+111.8%) | -$0.35(-166.0%) | -$0.35(-45.3%) |
| Sept 2018 | - | $0.53(-1866.7%) | -$0.64(-39.0%) |
| June 2018 | - | -$0.03(-94.0%) | -$1.05(-7.1%) |
| Mar 2018 | - | -$0.50(-21.9%) | -$1.13(+564.7%) |
| Dec 2017 | -$0.17(-150.0%) | -$0.64(-633.3%) | -$0.17(-140.5%) |
| Sept 2017 | - | $0.12(-209.1%) | $0.42(-30.0%) |
| June 2017 | - | -$0.11(-123.9%) | $0.60(-38.1%) |
| Mar 2017 | - | $0.46(-1020.0%) | $0.97(+203.1%) |
| Dec 2016 | $0.34(-157.6%) | -$0.05(-116.7%) | $0.32(+52.4%) |
| Sept 2016 | - | $0.30(+15.4%) | $0.21(-177.8%) |
| June 2016 | - | $0.26(-236.8%) | -$0.27(-58.5%) |
| Mar 2016 | - | -$0.19(+18.8%) | -$0.65(+10.2%) |
| Dec 2015 | -$0.59(+7.3%) | -$0.16(-11.1%) | -$0.59(+3.5%) |
| Sept 2015 | - | -$0.18(+50.0%) | -$0.57(+11.8%) |
| June 2015 | - | -$0.12(-7.7%) | -$0.51(-7.3%) |
| Mar 2015 | - | -$0.13(-7.1%) | -$0.55(-1.8%) |
| Dec 2014 | -$0.55(-32.1%) | -$0.14(+16.7%) | -$0.56(-28.2%) |
| Sept 2014 | - | -$0.12(-25.0%) | -$0.78(-4.9%) |
| June 2014 | - | -$0.16(+14.3%) | -$0.82(+2.5%) |
| Mar 2014 | - | -$0.14(-61.1%) | -$0.80(-1.2%) |
| Dec 2013 | -$0.81(+84.1%) | -$0.36(+125.0%) | -$0.81(+42.1%) |
| Sept 2013 | - | -$0.16(+14.3%) | -$0.57(+11.8%) |
| June 2013 | - | -$0.14(-6.7%) | -$0.51(+6.3%) |
| Mar 2013 | - | -$0.15(+25.0%) | -$0.48(+11.6%) |
| Dec 2012 | -$0.44(+25.7%) | -$0.12(+20.0%) | -$0.43(0.0%) |
| Sept 2012 | - | -$0.10(-9.1%) | -$0.43(+4.9%) |
| June 2012 | - | -$0.11(+10.0%) | -$0.41(+5.1%) |
| Mar 2012 | - | -$0.10(-16.7%) | -$0.39(+8.3%) |
| Dec 2011 | -$0.35(+25.0%) | -$0.12(+50.0%) | -$0.36(+20.0%) |
| Sept 2011 | - | -$0.08(-11.1%) | -$0.30(-9.1%) |
| June 2011 | - | -$0.09(+28.6%) | -$0.33(+10.0%) |
| Mar 2011 | - | -$0.07(+16.7%) | -$0.30(+11.1%) |
| Dec 2010 | -$0.28(+55.6%) | -$0.06(-45.5%) | -$0.27(+80.0%) |
| Sept 2010 | - | -$0.11(+83.3%) | -$0.15(0.0%) |
| June 2010 | - | -$0.06(+50.0%) | -$0.15(+7.1%) |
| Mar 2010 | - | -$0.04(-166.7%) | -$0.14(-12.5%) |
| Dec 2009 | -$0.18(+12.5%) | $0.06(-154.5%) | -$0.16(-44.8%) |
| Sept 2009 | - | -$0.11(+120.0%) | -$0.29(+26.1%) |
| June 2009 | - | -$0.05(-16.7%) | -$0.23(+9.5%) |
| Mar 2009 | - | -$0.06(-14.3%) | -$0.21(+23.5%) |
| Dec 2008 | -$0.16 | -$0.07(+40.0%) | -$0.17(+54.5%) |
| Sept 2008 | - | -$0.05(+66.7%) | -$0.11(+57.1%) |
| June 2008 | - | -$0.03(+50.0%) | -$0.07(+16.7%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Mar 2008 | - | -$0.02(+100.0%) | -$0.06(0.0%) |
| Dec 2007 | -$0.06(-25.0%) | -$0.01(0.0%) | -$0.06(-10.2%) |
| Sept 2007 | - | -$0.01(-50.0%) | -$0.07(-13.0%) |
| June 2007 | - | -$0.02(0.0%) | -$0.08(-11.5%) |
| Mar 2007 | - | -$0.02(+19.0%) | -$0.09(0.0%) |
| Dec 2006 | -$0.08(-33.3%) | -$0.02(-16.0%) | -$0.09(-13.2%) |
| Sept 2006 | - | -$0.02(-33.3%) | -$0.10(0.0%) |
| June 2006 | - | -$0.03(+50.0%) | -$0.10(+11.1%) |
| Mar 2006 | - | -$0.02(-33.3%) | -$0.09(-18.2%) |
| Dec 2005 | -$0.12(-33.3%) | -$0.03(+50.0%) | -$0.11(0.0%) |
| Sept 2005 | - | -$0.02(0.0%) | -$0.11(-8.3%) |
| June 2005 | - | -$0.02(-50.0%) | -$0.12(0.0%) |
| Mar 2005 | - | -$0.04(+33.3%) | -$0.12(-33.3%) |
| Dec 2004 | -$0.18(+50.0%) | -$0.03(0.0%) | -$0.18(-5.3%) |
| Sept 2004 | - | -$0.03(+50.0%) | -$0.19(+46.2%) |
| June 2004 | - | -$0.02(-80.0%) | -$0.13(-23.5%) |
| Mar 2004 | - | -$0.10(+150.0%) | -$0.17(+30.8%) |
| Dec 2003 | -$0.12(-47.8%) | -$0.04(-233.3%) | -$0.13(-11.9%) |
| Sept 2003 | - | $0.03(-150.0%) | -$0.15(-35.1%) |
| June 2003 | - | -$0.06(0.0%) | -$0.23(-4.2%) |
| Mar 2003 | - | -$0.06(+4.2%) | -$0.24(0.0%) |
| Dec 2002 | -$0.23(-28.1%) | -$0.06(+15.2%) | -$0.24(+1.8%) |
| Sept 2002 | - | -$0.05(-28.6%) | -$0.23(-11.4%) |
| June 2002 | - | -$0.07(+16.7%) | -$0.26(-10.2%) |
| Mar 2002 | - | -$0.06(+12.1%) | -$0.29(-6.4%) |
| Dec 2001 | -$0.32(-27.3%) | -$0.05(-33.1%) | -$0.31(-10.9%) |
| Sept 2001 | - | -$0.08(-20.0%) | -$0.35(-7.9%) |
| June 2001 | - | -$0.10(+25.0%) | -$0.38(-5.0%) |
| Mar 2001 | - | -$0.08(-12.9%) | -$0.40(-9.1%) |
| Dec 2000 | -$0.44(-13.7%) | -$0.09(-16.5%) | -$0.44(-7.9%) |
| Sept 2000 | - | -$0.11(-8.3%) | -$0.48(-17.2%) |
| June 2000 | - | -$0.12(0.0%) | -$0.58(+5.5%) |
| Mar 2000 | - | -$0.12(-7.7%) | -$0.55(+7.8%) |
| Dec 1999 | -$0.51(+142.9%) | -$0.13(-38.1%) | -$0.51(+34.2%) |
| Sept 1999 | - | -$0.21(+133.3%) | -$0.38(+35.7%) |
| June 1999 | - | -$0.09(+12.5%) | -$0.28(+16.7%) |
| Mar 1999 | - | -$0.08(-27.3%) | -$0.24(-27.3%) |
| Dec 1998 | -$0.21(-40.0%) | - | - |
| Sept 1998 | - | -$0.11(+120.0%) | -$0.33(+3.1%) |
| June 1998 | - | -$0.05(-54.5%) | -$0.32(-15.8%) |
| June 1998 | -$0.35(0.0%) | - | - |
| Mar 1998 | - | -$0.11(+83.3%) | -$0.38(+15.2%) |
| Dec 1997 | - | -$0.06(-40.0%) | -$0.33(-8.3%) |
| Sept 1997 | - | -$0.10(-9.1%) | -$0.36(+2.9%) |
| June 1997 | -$0.35(+40.0%) | -$0.11(+83.3%) | -$0.35(+12.9%) |
| Mar 1997 | - | -$0.06(-33.3%) | -$0.31(-3.1%) |
| Dec 1996 | - | -$0.09(0.0%) | -$0.32(+6.7%) |
| Sept 1996 | - | -$0.09(+28.6%) | -$0.30(+20.0%) |
| June 1996 | -$0.25(-16.7%) | -$0.07(0.0%) | -$0.25(-7.4%) |
| Mar 1996 | - | -$0.07(0.0%) | -$0.27(0.0%) |
| Dec 1995 | - | -$0.07(+75.0%) | -$0.27(-3.6%) |
| Sept 1995 | - | -$0.04(-55.6%) | -$0.28(-6.7%) |
| June 1995 | -$0.30(+20.0%) | -$0.09(+28.6%) | -$0.30(+11.1%) |
| Mar 1995 | - | -$0.07(-12.5%) | -$0.27(+8.0%) |
| Dec 1994 | - | -$0.08(+33.3%) | -$0.25(0.0%) |
| Sept 1994 | - | -$0.06(0.0%) | -$0.25(0.0%) |
| June 1994 | -$0.25(+8.7%) | -$0.06(+20.0%) | -$0.25(-3.8%) |
| Mar 1994 | - | -$0.05(-37.5%) | -$0.26(0.0%) |
| Dec 1993 | - | -$0.08(+33.3%) | -$0.26(+8.3%) |
| Sept 1993 | - | -$0.06(-14.3%) | -$0.24(+4.3%) |
| June 1993 | -$0.23(+27.8%) | -$0.07(+40.0%) | -$0.23(+15.6%) |
| Mar 1993 | - | -$0.05(-16.7%) | -$0.20(+5.3%) |
| Dec 1992 | - | -$0.06(+20.0%) | -$0.19(+46.5%) |
| Sept 1992 | - | -$0.05(+28.2%) | -$0.13(+63.3%) |
| June 1992 | -$0.18 | -$0.04(-2.5%) | -$0.08(+97.5%) |
| Mar 1992 | - | -$0.04 | -$0.04 |
FAQ
- What is Lineage Cell Therapeutics annual earnings per share?
- What is the all time high annual EPS for Lineage Cell Therapeutics?
- What is Lineage Cell Therapeutics annual EPS year-on-year change?
- What is Lineage Cell Therapeutics quarterly earnings per share?
- What is the all time high quarterly EPS for Lineage Cell Therapeutics?
- What is Lineage Cell Therapeutics quarterly EPS year-on-year change?
- What is Lineage Cell Therapeutics TTM earnings per share?
- What is the all time high TTM EPS for Lineage Cell Therapeutics?
- What is Lineage Cell Therapeutics TTM EPS year-on-year change?
What is Lineage Cell Therapeutics annual earnings per share?
The current annual EPS of LCTX is -$0.12
What is the all time high annual EPS for Lineage Cell Therapeutics?
Lineage Cell Therapeutics all-time high annual earnings per share is $0.34
What is Lineage Cell Therapeutics annual EPS year-on-year change?
Over the past year, LCTX annual earnings per share has changed by +$0.03 (+20.00%)
What is Lineage Cell Therapeutics quarterly earnings per share?
The current quarterly EPS of LCTX is -$0.02
What is the all time high quarterly EPS for Lineage Cell Therapeutics?
Lineage Cell Therapeutics all-time high quarterly earnings per share is $0.53
What is Lineage Cell Therapeutics quarterly EPS year-on-year change?
Over the past year, LCTX quarterly earnings per share has changed by +$0.02 (+50.00%)
What is Lineage Cell Therapeutics TTM earnings per share?
The current TTM EPS of LCTX is -$0.11
What is the all time high TTM EPS for Lineage Cell Therapeutics?
Lineage Cell Therapeutics all-time high TTM earnings per share is $0.97
What is Lineage Cell Therapeutics TTM EPS year-on-year change?
Over the past year, LCTX TTM earnings per share has changed by +$0.02 (+15.38%)